SCHEMBL6980719

SCHEMBL6980719

CC(C)(C)[C](c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PTGS2 P35354 1/20 0.42
PLA2G7 Q13093 1/20 0.42
NFE2L2 Q16236 1/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RECQL P46063 1/20 0.40
PKM P14618 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
BCL2L1 Q07817 1/20 0.39
BAD Q92934 1/20 0.39
LMNA P02545 1/20 0.39
ALPG P10696 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709683 0.86 POLB (0.42) POLBTDP1PKMCES2CES1
SCHEMBL6985058 0.80 CES1 (0.46) NPC1RAB9ASMN1; SMN2PTGS2PLA2G7
SCHEMBL6986994 0.78 NFE2L2 (0.41) NPC1RAB9ASMN1; SMN2PTGS2PLA2G7
SCHEMBL9729472 0.75 NPC1 (0.47) NPC1RAB9ASMN1; SMN2PTGS2MEN1
SCHEMBL6312637 0.74 NPC1 (0.48) NPC1RAB9ASMN1; SMN2NFE2L2MEN1
SCHEMBL10518218 0.74 NPC1 (0.48) NPC1RAB9ASMN1; SMN2NFE2L2MEN1
SCHEMBL8212756 0.74 CES2 (0.48) NPC1RAB9ASMN1; SMN2PTGS2MEN1
SCHEMBL25501695 0.71 ESR1 (0.47) NPC1RAB9ASMN1; SMN2PTGS2MEN1
SCHEMBL6985545 0.71 ALDH1A1 (0.48) NPC1RAB9ASMN1; SMN2CES1LMNA
SCHEMBL7940672 0.71 HPGD (0.51) NPC1RAB9ASMN1; SMN2MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294695-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-03-26 EP claimed
WO-2001085694-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-15 WO claimed
WO-2015095337-A2 PYRAZOLO[1,5-a]PYRIMIDINECARBOXAMIDE DERIVATIVES FOR TREATING COGNITIVE IMPAIRMENT THE ROCKEFELLER UNIVERSITY (US) 2015-06-25 WO disclosed